[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-350004-105":59,"doc-detail-350004-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","diagnostic-outcomes-among-patients-with-positive-multi-cancer-early-detection-test-results-open-access","Diagnostic Outcomes among Patients with Positive Multi-Cancer Early Detection Test Results - Open Access","","Multi-cancer early detection (MCED) tests enable detection of multiple cancers through a single screening assay. In December 2023, Dana-Farber Cancer Institute launched an MCED clinical and research program for patients with positive results and to study MCED use in practice. The report summarizes a prospective case series of patients with a signal detected by the Grail Galleri MCED test who underwent diagnostic evaluation between December 2023 and January 2025. Primary outcomes included cancer confirmation, time to diagnostic resolution, and cancer signal origin accuracy, with 78.6% confirmed diagnoses.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/diagnostic-outcomes-among-patients-with-positive-multi-cancer-early-detection-test-results-open-access/350004/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/diagnostic-outcomes-among-patients-with-positive-multi-cancer-early-detection-test-results-open-access/350004.png","ImageObject",300,407,{"name":92,"@type":93},"\tJames","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-07","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What outcomes were evaluated for patients with positive MCED results?","Question",{"text":112,"@type":113},"The study prioritized confirmation of a cancer diagnosis, the time to diagnostic resolution, and the accuracy of the cancer signal origin (CSO) suggested by the MCED test.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What proportion of positive MCED tests led to confirmed cancer diagnoses?",{"text":117,"@type":113},"Among 14 patients with positive MCED tests, 78.6% had confirmed cancer diagnoses, while 21.4% were false positives.",{"name":119,"@type":110,"acceptedAnswer":120},"How quickly were patients evaluated after receiving MCED results?",{"text":121,"@type":113},"The median time from the MCED test result to presentation at the DFCI MCED clinic was 28 days, and the median time from presentation to diagnostic resolution was 20 days.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},350004,1790236473,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":24,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},2336474466412,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","RESEARCH ARTICLE  [https://doi.org/10.1158/2767-9764.CRC-25-0723](https://doi.org/10.1158/2767-9764.CRC-25-0723)  OPEN ACCESS  \nDiagnostic Outcomes among Patients with Positive Multi-Cancer Early Detection Test Results  \nElizabeth K. O’Donnell1,2, Tia L. Kauffman1, Sydney Asnis1, Victoria A. Kelly1, Ella Matthews1, Matheos Kartsounis1, Harita Dharaneeswaran1, Jenna B. Beckwith1, Ciola Bennett1, Marjorie Marto1, Giovanni Parmigiani1,3, Timothy R. Rebbeck1,3, Irene M. Ghobrial1,2, Sapna Syngal1,2,4, and Catherine R. Marinac1,2  \n􀀶  \nABSTRACT  \nMulti-cancer early detection (MCED) tests represent a significant technological advancement, allowing for the detection of multiple cancers through a single screening test. In December 2023, Dana-Farber Cancer Institute (DFCI) initiated an MCED clinical and research program to serve patients receiving positive MCED test results and further study MCED tests in clinical practice. Prospective case series reporting on patients with a signal detected by the Grail Galleri MCED test who presented for diagnostic evaluation at DFCI between December 2023 and January 2025. Primary outcomes were confirmation of cancer diagnosis, time to diagnostic resolution, and accuracy of the cancer signal origin (CSO) suggested. Of the 14 patients with a positive MCED test, 78.6% had a confirmed cancer diagnosis, whereas 21.4% were false positives. The median age was 62.5 years, with 64.3% male and 85.7% White, nonHispanic. The median time from MCED test result to presentation at the  \nDFCI MCED clinic was 28 days. The median time from MCED clinic presentation to diagnostic resolution was 20 days. Among confirmed cases, 54.5% were solid tumors and 45.5% were hematologic malignancies. More than 90% of detected malignancies lack current screening guidelines. Six cancers were diagnosed at stage I/II, and five at III/IV. Most patients with a cancer signal detected on a MCED test were true positives with a cancer consistent with the CSO reported. Patients had their MCED test results quickly adjudicated when presenting to a dedicated clinical program supporting a role for cancer diagnostic expertise in evaluating MCED tests.  \nSignificance: MCED tests are a new and evolving technology that may help detect cancer early on. Here, we report the experience of a dedicated cancer clinic in evaluating patients with a positive cancer signal from an MCED test.  \nIntroduction  \nCancer remains a major public health challenge in the United States, with an estimated 2,041,910 new cancer cases and 618,120 cancer-related deaths projected in 2025 ( 1) . Most cancers currently lack guidelines for recommended screening protocols ( 1) . Although established cancer screening guidelines for breast, cervical, colorectal, and lung cancers have enabled early detection in some individuals (2–8), adherence to guideline-based screening  \n1Dana-Farber Cancer Institute, Boston, Massachusetts. 2Harvard Medical School, Boston, Massachusetts. 3Harvard T. H. Chan School of Public Health, Boston, Massachusetts. 4Brigham and Women’s Hospital, Boston, Massachusetts. Corresponding Author: Elizabeth K. O’Donnell, Medical Oncology, DanaFarber Cancer Institute, 450 Brookline Ave, Boston, MA 02215. E-mail:  \n[elizabeth_odonnell@dfci.harvard.edu](elizabeth_odonnell@dfci.harvard.edu)  \n[doi:](doi: 10.1158/2767-9764)[ 10.1158/2767-9764](doi: 10.1158/2767-9764) .CRC-25-0723  \nThis open access article is distributed under the Creative Commons Attribution 4.0 International (CC BY 4.0) license.  \n©2026 The Authors; Published by the American Association for Cancer Research  \nis incomplete and varies widely across populations. As a result, the vast majority of cancers are usually detected incidentally or when a patient presents to their provider with symptoms, at which point the disease is often more advanced.  \nRecent technological advancements have facilitated the development of blood-based multi-cancer early detection (MCED) tests, which use a single test to detect ","cbCaiatkICM1bweM","https://ap.wps.com/l/cbCaiatkICM1bweM","pdf",1231729,"English","# Abstract\n## Significance\n# Introduction\n## Cancer burden and screening gaps\n## Blood-based MCED test rationale\n## Clinical adoption challenges\n## DFCI MCED program","[{\"question\":\"What outcomes were evaluated for patients with positive MCED results?\",\"answer\":\"The study prioritized confirmation of a cancer diagnosis, the time to diagnostic resolution, and the accuracy of the cancer signal origin (CSO) suggested by the MCED test.\"},{\"question\":\"What proportion of positive MCED tests led to confirmed cancer diagnoses?\",\"answer\":\"Among 14 patients with positive MCED tests, 78.6% had confirmed cancer diagnoses, while 21.4% were false positives.\"},{\"question\":\"How quickly were patients evaluated after receiving MCED results?\",\"answer\":\"The median time from the MCED test result to presentation at the DFCI MCED clinic was 28 days, and the median time from presentation to diagnostic resolution was 20 days.\"}]","Diagnostic Outcomes among Patients with Positive Multi-Cancer Early Detection Test Results - Open Access | PDF",1790086685,13,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a709275cf5fab0960e18f5589aa5a225.webp",983,1263,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c039f9755b81a823a52fc3f64b498b39.webp",982,1262,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b2055b8f2f087fcbc5f3384786e5c28e.webp",981,1261,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c1de75fafd83e928517070f70968ebbb.webp",980,1259]